+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Glaucoma Market - Global Forecast 2026-2032- Product Image
Glaucoma Market - Global Forecast 2026-2032- Product Image
New

Glaucoma Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 194 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6017423
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The glaucoma market is evolving quickly, propelled by clinical complexity, technological advancements, and shifting patient management strategies. Leaders in the industry are seeking actionable market intelligence to optimize decisions, manage supply risk, and strengthen commercial and clinical outcomes in a demanding regulatory landscape.

Glaucoma Market Snapshot

The Glaucoma Market expanded from USD 8.04 billion in 2025 to USD 8.52 billion in 2026 and is projected to achieve a 5.78% CAGR, reaching USD 11.93 billion by 2032. This growth is underpinned by new diagnostic tools, minimally invasive surgical options, and pharmaceutical innovation. Increasing emphasis on accurate detection and sustained therapy is driving investments from device manufacturers, health systems, and pharmaceutical developers.

Scope & Segmentation Analysis

This report delivers a comprehensive overview of the glaucoma industry by profiling technologies, applications, and stakeholders across global regions.

  • Product Types: Diagnostic and monitoring devices, surgical devices, and therapeutics targeting diverse mechanisms of action and dosing regimens
  • Diagnostic Solutions: Fundus cameras, optical coherence tomography, pachymeters, perimetry systems, and tonometry devices supporting early detection and ongoing monitoring
  • Surgical Innovations: Glaucoma drainage implants, laser and micro-invasive surgical devices (e.g., Hydrus, iStent, Xen Gel Stent), and traditional trabeculectomy solutions reshaping referral and procedural models
  • Therapeutic Classes: Alpha agonists, beta blockers, carbonic anhydrase inhibitors, combination drugs, miotics, prostaglandin analogues, and rho kinase inhibitors, alongside advances in neuroprotection and sustained-release delivery
  • End Users: Ambulatory surgical centers, hospitals, ophthalmic clinics, and expanding home care settings influencing adoption and service innovation
  • Distribution Channels: Hospital, online, and retail pharmacies affecting medication access and fulfillment efficiencies
  • Routes of Administration: Topical, oral, and intravenous pathways determining workflow complexity and adherence dynamics
  • Regions: Americas, Europe, Middle East & Africa, Asia-Pacific—each with distinct clinical, regulatory, and commercial characteristics

Key Takeaways for Senior Stakeholders

  • Advanced imaging, artificial intelligence, and interoperability are driving earlier detection, personalized treatment, and workflow optimization across care settings.
  • New surgical device classes are redefining risk-benefit considerations, bringing minimally invasive techniques forward in the patient pathway and altering traditional surgical timing.
  • Cost containment strategies and evolving reimbursement frameworks are reinforcing the need for robust long-term clinical evidence and demonstrable value in payer negotiations.
  • Integrated care models are increasingly bridging ambulatory surgical centers, clinics, and remote settings to support consistent monitoring and adherence solutions.
  • Corporate strategies now emphasize technology partnerships, modular commercialization, and tailored go-to-market sequencing aligned with regional best practices.

Tariff Impact on Supply Chains and Market Access

Recent tariffs on medical devices and components have intensified supply chain risk, particularly for manufacturers sourcing cross-border components. This environment elevates input costs and compresses distributor margins, compelling organizations to adopt dual-sourcing strategies, invest in supplier diversification, and restructure procurement contracts. Tariff measures may delay product launches and slow the adoption of capital-intensive systems, especially in lower-margin settings or when regulatory approval is pending. Commercial teams are mitigating volatility by redesigning components, communicating value to payers, and modeling multiple procurement scenarios to maintain access and minimize business disruption.

Methodology & Data Sources

Findings are rooted in primary research through structured interviews with clinicians, procurement leaders, and distributors, supplemented by expert advisory insights. Secondary synthesis draws from peer-reviewed clinical literature, regulatory filings, and public health authority guidance to ensure completeness and reliability. Validation included cross-checking with independent experts and scenario analysis for tariff impacts.

Why This Report Matters

  • Enables C-suite, commercial, and product leaders to benchmark strategic options using fresh, validated market intelligence
  • Provides clarity on supply chain vulnerabilities and mitigations in the context of global trade and sourcing risk
  • Equips stakeholders to navigate evolving payer demands and support product adoption with evidence-backed positioning and regional insights

Conclusion

Well-timed decisions in evidence generation, supply resilience, and payer engagement will influence both short-term performance and long-term leadership in the glaucoma sector. Investing in agility and collaborative evidence building is key to unlocking opportunities and strengthening market position.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Glaucoma Market, by Product Type
8.1. Diagnostic & Monitoring Devices
8.1.1. Fundus Cameras
8.1.2. Optical Coherence Tomography
8.1.3. Pachymeters
8.1.4. Perimetry Devices
8.1.5. Tonometry Devices
8.2. Surgical Devices
8.2.1. Glaucoma Drainage Implants
8.2.2. Laser Devices
8.2.3. Micro-Invasive Glaucoma Surgery Devices
8.2.3.1. Hydrus
8.2.3.2. IStent
8.2.3.3. Xen Gel Stent
8.2.4. Trabeculectomy Devices
8.3. Therapeutics
8.3.1. Alpha Agonists
8.3.2. Beta Blockers
8.3.3. Carbonic Anhydrase Inhibitors
8.3.4. Combination Drugs
8.3.5. Miotics
8.3.6. Prostaglandin Analogues
8.3.7. Rho Kinase Inhibitors
9. Glaucoma Market, by Route Of Administration
9.1. Intravenous
9.2. Oral
9.3. Topical
10. Glaucoma Market, by End User
10.1. Ambulatory Surgical Centers
10.2. Home Care Settings
10.3. Hospitals
10.4. Ophthalmic Clinics
11. Glaucoma Market, by Distribution Channel
11.1. Hospital Pharmacies
11.2. Online Pharmacies
11.3. Retail Pharmacies
12. Glaucoma Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Glaucoma Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Glaucoma Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Glaucoma Market
16. China Glaucoma Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. AbbVie Inc.
17.6. Accutome, Inc.
17.7. Akorn Operating Company LLC
17.8. Alcon Vision LLC
17.9. Amorphex Therapeutics LLC
17.10. ASICO LLC
17.11. Bausch + Lomb Corporation
17.12. Bayer AG
17.13. Carl Zeiss Meditec AG
17.14. Fera Pharmaceuticals, LLC
17.15. Glaukos Corporation
17.16. Inotek Pharmaceuticals
17.17. Lumenis Be Ltd.
17.18. Merck & Co, Inc.
17.19. Mobius Therapeutics, LLC
17.20. NIDEK CO., LTD.
17.21. Novartis AG
17.22. Ocular Therapeutix, Inc.
17.23. Perrigo Company PLC
17.24. Pfizer, Inc.
17.25. pSivida Corp.
17.26. Quantel Medical
17.27. Santen Pharmaceutical Co., Ltd.
17.28. Teva Pharmaceutical Industries Ltd.
17.29. Topcon Corporation
List of Figures
FIGURE 1. GLOBAL GLAUCOMA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL GLAUCOMA MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL GLAUCOMA MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL GLAUCOMA MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GLAUCOMA MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL GLAUCOMA MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GLAUCOMA MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES GLAUCOMA MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA GLAUCOMA MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL GLAUCOMA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GLAUCOMA MARKET SIZE, BY FUNDUS CAMERAS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GLAUCOMA MARKET SIZE, BY FUNDUS CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GLAUCOMA MARKET SIZE, BY FUNDUS CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GLAUCOMA MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GLAUCOMA MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GLAUCOMA MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL GLAUCOMA MARKET SIZE, BY PACHYMETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL GLAUCOMA MARKET SIZE, BY PACHYMETERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GLAUCOMA MARKET SIZE, BY PACHYMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GLAUCOMA MARKET SIZE, BY PERIMETRY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GLAUCOMA MARKET SIZE, BY PERIMETRY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GLAUCOMA MARKET SIZE, BY PERIMETRY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GLAUCOMA MARKET SIZE, BY TONOMETRY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GLAUCOMA MARKET SIZE, BY TONOMETRY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL GLAUCOMA MARKET SIZE, BY TONOMETRY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GLAUCOMA MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GLAUCOMA MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GLAUCOMA MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GLAUCOMA MARKET SIZE, BY LASER DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GLAUCOMA MARKET SIZE, BY LASER DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GLAUCOMA MARKET SIZE, BY LASER DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GLAUCOMA MARKET SIZE, BY HYDRUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GLAUCOMA MARKET SIZE, BY HYDRUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GLAUCOMA MARKET SIZE, BY HYDRUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL GLAUCOMA MARKET SIZE, BY ISTENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL GLAUCOMA MARKET SIZE, BY ISTENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL GLAUCOMA MARKET SIZE, BY ISTENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL GLAUCOMA MARKET SIZE, BY XEN GEL STENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL GLAUCOMA MARKET SIZE, BY XEN GEL STENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL GLAUCOMA MARKET SIZE, BY XEN GEL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL GLAUCOMA MARKET SIZE, BY TRABECULECTOMY DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GLAUCOMA MARKET SIZE, BY TRABECULECTOMY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GLAUCOMA MARKET SIZE, BY TRABECULECTOMY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL GLAUCOMA MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL GLAUCOMA MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL GLAUCOMA MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL GLAUCOMA MARKET SIZE, BY ALPHA AGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL GLAUCOMA MARKET SIZE, BY ALPHA AGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL GLAUCOMA MARKET SIZE, BY ALPHA AGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GLAUCOMA MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GLAUCOMA MARKET SIZE, BY BETA BLOCKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GLAUCOMA MARKET SIZE, BY BETA BLOCKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GLAUCOMA MARKET SIZE, BY CARBONIC ANHYDRASE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL GLAUCOMA MARKET SIZE, BY CARBONIC ANHYDRASE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GLAUCOMA MARKET SIZE, BY CARBONIC ANHYDRASE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GLAUCOMA MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GLAUCOMA MARKET SIZE, BY COMBINATION DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GLAUCOMA MARKET SIZE, BY COMBINATION DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL GLAUCOMA MARKET SIZE, BY MIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL GLAUCOMA MARKET SIZE, BY MIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GLAUCOMA MARKET SIZE, BY MIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GLAUCOMA MARKET SIZE, BY PROSTAGLANDIN ANALOGUES, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GLAUCOMA MARKET SIZE, BY PROSTAGLANDIN ANALOGUES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL GLAUCOMA MARKET SIZE, BY PROSTAGLANDIN ANALOGUES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL GLAUCOMA MARKET SIZE, BY RHO KINASE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL GLAUCOMA MARKET SIZE, BY RHO KINASE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL GLAUCOMA MARKET SIZE, BY RHO KINASE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL GLAUCOMA MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL GLAUCOMA MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL GLAUCOMA MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL GLAUCOMA MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL GLAUCOMA MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL GLAUCOMA MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL GLAUCOMA MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL GLAUCOMA MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL GLAUCOMA MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL GLAUCOMA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL GLAUCOMA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL GLAUCOMA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL GLAUCOMA MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL GLAUCOMA MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL GLAUCOMA MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL GLAUCOMA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL GLAUCOMA MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL GLAUCOMA MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL GLAUCOMA MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL GLAUCOMA MARKET SIZE, BY OPHTHALMIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL GLAUCOMA MARKET SIZE, BY OPHTHALMIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL GLAUCOMA MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL GLAUCOMA MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL GLAUCOMA MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL GLAUCOMA MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL GLAUCOMA MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL GLAUCOMA MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL GLAUCOMA MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL GLAUCOMA MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL GLAUCOMA MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL GLAUCOMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS GLAUCOMA MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 143. EUROPE GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. EUROPE GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. EUROPE GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 146. EUROPE GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 147. EUROPE GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 148. EUROPE GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 149. EUROPE GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 150. EUROPE GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. EUROPE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 154. MIDDLE EAST GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. AFRICA GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. AFRICA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 163. AFRICA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 164. AFRICA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 165. AFRICA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 166. AFRICA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 167. AFRICA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 168. AFRICA GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. AFRICA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL GLAUCOMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. ASEAN GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. ASEAN GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. ASEAN GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 183. ASEAN GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 184. ASEAN GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 185. ASEAN GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 186. ASEAN GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 187. ASEAN GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. ASEAN GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. GCC GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. GCC GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. GCC GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 192. GCC GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 193. GCC GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 194. GCC GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 195. GCC GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 196. GCC GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. GCC GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 207. BRICS GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. BRICS GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 209. BRICS GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 210. BRICS GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 211. BRICS GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 212. BRICS GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 213. BRICS GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 214. BRICS GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. BRICS GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 216. G7 GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. G7 GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 218. G7 GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 219. G7 GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 220. G7 GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 221. G7 GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 222. G7 GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 223. G7 GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. G7 GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 225. NATO GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. NATO GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 227. NATO GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 228. NATO GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 229. NATO GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 230. NATO GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 231. NATO GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 232. NATO GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. NATO GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 234. GLOBAL GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES GLAUCOMA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 244. CHINA GLAUCOMA MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 245. CHINA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 246. CHINA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 247. CHINA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 248. CHINA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2032 (USD MILLION)
TABLE 249. CHINA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 250. CHINA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 251. CHINA GLAUCOMA MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 252. CHINA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Glaucoma market report include:
  • AbbVie Inc.
  • Accutome, Inc.
  • Akorn Operating Company LLC
  • Alcon Vision LLC
  • Amorphex Therapeutics LLC
  • ASICO LLC
  • Bausch + Lomb Corporation
  • Bayer AG
  • Carl Zeiss Meditec AG
  • Fera Pharmaceuticals, LLC
  • Glaukos Corporation
  • Inotek Pharmaceuticals
  • Lumenis Be Ltd.
  • Merck & Co, Inc.
  • Mobius Therapeutics, LLC
  • NIDEK CO., LTD.
  • Novartis AG
  • Ocular Therapeutix, Inc.
  • Perrigo Company PLC
  • Pfizer, Inc.
  • pSivida Corp.
  • Quantel Medical
  • Santen Pharmaceutical Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Topcon Corporation

Table Information

Report AttributeDetails
No. of Pages194
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 8.52 Billion
Forecasted Market Value ( USD ) by 2032 $ 11.93 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Glaucoma Treatment Market - Global Forecast 2026-2032 - Product Image

Glaucoma Treatment Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Glaucoma Therapeutics Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034) - Product Image

Glaucoma Therapeutics Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Open-Angle Glaucoma Therapeutics Market - Global Forecast 2026-2032 - Product Image

Open-Angle Glaucoma Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Glaucoma Market Report 2025 - Product Image

Glaucoma Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Glaucoma Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Glaucoma Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Glaucoma Market

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss. Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.